Compare AANJANEYA LIFECARE with ASTRAZENECA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ASTRAZENECA PHARMA - Comparison Results

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ASTRAZENECA PHARMA DR. DATSONS LABS/
ASTRAZENECA PHARMA
 
P/E (TTM) x -10.9 126.0 - View Chart
P/BV x 0.2 38.6 0.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ASTRAZENECA PHARMA
Mar-18
DR. DATSONS LABS/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1261,278 9.8%   
Low Rs31883 3.5%   
Sales per share (Unadj.) Rs133.0228.4 58.2%  
Earnings per share (Unadj.) Rs0.210.4 1.5%  
Cash flow per share (Unadj.) Rs6.616.3 40.6%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.898.8 130.4%  
Shares outstanding (eoy) m31.6625.00 126.6%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.7 12.4%   
Avg P/E ratio x516.1104.2 495.2%  
P/CF ratio (eoy) x11.866.4 17.8%  
Price / Book Value ratio x0.610.9 5.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,47727,008 9.2%   
No. of employees `000NA1.4 0.0%   
Total wages/salary Rs m561,535 3.6%   
Avg. sales/employee Rs ThNM4,210.9-  
Avg. wages/employee Rs ThNM1,132.2-  
Avg. net profit/employee Rs ThNM191.1-  
INCOME DATA
Net Sales Rs m4,2115,710 73.7%  
Other income Rs m79123 64.2%   
Total revenues Rs m4,2895,833 73.5%   
Gross profit Rs m569463 122.8%  
Depreciation Rs m204147 138.7%   
Interest Rs m4300-   
Profit before tax Rs m13438 2.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6179 3.4%   
Profit after tax Rs m5259 1.9%  
Gross profit margin %13.58.1 166.6%  
Effective tax rate %48.040.8 117.6%   
Net profit margin %0.14.5 2.5%  
BALANCE SHEET DATA
Current assets Rs m6,8523,209 213.5%   
Current liabilities Rs m6,7112,070 324.3%   
Net working cap to sales %3.320.0 16.8%  
Current ratio x1.01.6 65.8%  
Inventory Days Days16172 222.4%  
Debtors Days Days31835 912.0%  
Net fixed assets Rs m3,673790 464.8%   
Share capital Rs m31750 633.2%   
"Free" reserves Rs m3,7612,419 155.5%   
Net worth Rs m4,0782,469 165.1%   
Long term debt Rs m1,6710-   
Total assets Rs m12,6334,605 274.3%  
Interest coverage x1.0NM-  
Debt to equity ratio x0.40-  
Sales to assets ratio x0.31.2 26.9%   
Return on assets %3.45.6 61.2%  
Return on equity %0.110.5 1.1%  
Return on capital %7.717.7 43.3%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m964300 321.8%   
Fx outflow Rs m6072,015 30.1%   
Net fx Rs m357-1,715 -20.8%   
CASH FLOW
From Operations Rs m1,34588 1,529.9%  
From Investments Rs m-2,256-94 2,409.8%  
From Financial Activity Rs m-1,200NA-  
Net Cashflow Rs m-2,111-6 37,029.8%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 0.3 -  
FIIs % 1.4 15.7 8.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 9.1 1,034.1%  
Shareholders   20,807 12,856 161.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ABBOTT INDIA  NATCO PHARMA  AJANTA PHARMA  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 211 m (down 21.2% YoY). Sales on the other hand came in at Rs 2 bn (down 10.5% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4% (Quarterly Result Update)

Sep 22, 2020 | Updated on Sep 22, 2020

For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

Shares of Oxygen Suppliers in Focus Amid Rising Demand for Oxygen (Company Info)

Apr 20, 2021

In this article, we discuss the hype around Oxygen supplier stocks and a little known NBFC company, which has rallied 150% in less than a month.

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5% (Quarterly Result Update)

May 20, 2020 | Updated on May 20, 2020

For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS